Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test
Meschi S, Colavita F, Bordi L, Matusali G, Lapa D, Amendola A, Vairo F, Ippolito G, Capobianchi MR, Castilletti C; INMICovid-19 laboratory team.J Clin Virol. (2020); 129:104539
Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples#3
B. Pastorino, F. Touret, M. Gilles, L. Luciani, X. de Lamballerie, R.N. Charrel.Viruses (2020); 12(6); 624
Trend of respiratory pathogens during the COVID-19 epidemic
G. Sberna, A. Amendola, M.B. Valli, et al.J Clin Virol (2020); 129:104470
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay
L. Bordi, A. Piralla, E. Lalle, et al.J Clin Virol (2020); 128; 104416